Reawakening of Nuclear Medicine through Molecular Imaging: Quantitative Theranostics and PSMA PET.

HomeRadiologyVol. 307, No. 4 PreviousNext Reviews and CommentaryEditorialReawakening of Nuclear Medicine through Molecular Imaging: Quantitative Theranostics and PSMA PETA. Cahid Civelek A. Cahid Civelek Author AffiliationsFrom the Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Johns Hopkins Medical Institutions, 601 N Caroline St, JHOC 3225, Baltimore, MD 21287.Address correspondence to the author (email: [email protected]).A. Cahid Civelek Published Online:Apr 18 2023https://doi.org/10.1148/radiol.230627MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In References1. SEER Cancer Stat Facts: Prostate Cancer Facts & Figures 2023. American Cancer Society. https://seer.cancer.gov/statfacts/html/prost.html. Accessed March 2023. Google Scholar2. Kranzbühler B, Müller J, Becker AS, et al. Detection Rate and Localization of Prostate Cancer Recurrence Using 68Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL. J Nucl Med 2020;61(2):194–201.https://doi.org/10.2967/jnumed.118.225276 Crossref, Medline, Google Scholar3. Martinez J, Subramanian K, Margolis D, et al. 68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study. Transl Oncol 2022;15(1):101242https://doi.org/10.1016/j.tranon.2021.101242. Crossref, Medline, Google Scholar4. Shagera QA, Artigas C, Karfis I, et al. 68Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy. J Nucl Med 2022;63(8):1191–1198. https://doi.org/10.2967/jnumed.121.263006 Crossref, Medline, Google Scholar5. Civelek AC. Management of Metastatic Prostate Cancer Biochemical Recurrence with Use of 18F-DCFPyL PET/CT. Radiology 2022;303(2):423–424. Link, Google Scholar6. Civelek AC. 68Ga-PSMA-11 PET: Better at Detecting Prostate Cancer than Multiparametric MRI? Radiology 2018;289(3):738–739. Link, Google Scholar7. Kambiz Rahbar et al. ASCO GU Cancer Symposium, February 16-18, 2023; and J Nucl Med. 2022 Oct 27;jnumed.122.264456. Google Scholar8. Wen X, Shi C, Yang L, et al. A radioiodinated FR-β-targeted tracer with improved pharmacokinetics through modification with an albumin binder for imaging of macrophages in AS and NAFL. Eur J Nucl Med Mol Imaging 2022;49(2):503–516. Crossref, Medline, Google Scholar9. Seifert R, Rasul S, Seitzer KE, et al. A Prognostic Risk Score for Prostate Cancer based on PSMA PET–derived Organ-Specific Tumor Volumes. Radiology 2023;307(4):e222010. Link, Google Scholar10. Lawhn-Heath C, Salavati A, Behr SC, et al. Prostate-specific Membrane Antigen PET in Prostate Cancer. Radiology 2021;299(2):248–260. Link, Google ScholarArticle HistoryReceived: Mar 12 2023Revision requested: Mar 17 2023Revision received: Mar 20 2023Accepted: Mar 21 2023Published online: Apr 18 2023 FiguresReferencesRelatedDetailsAccompanying This ArticleA Prognostic Risk Score for Prostate Cancer Based on PSMA PET–derived Organ-specific Tumor VolumesApr 18 2023RadiologyRecommended Articles Management of Metastatic Prostate Cancer Biochemical Recurrence with Use of 18F-DCFPyL PET/CTRadiology2022Volume: 303Issue: 2pp. 423-424Competitive Advantage of PSMA Theranostics in Prostate CancerRadiology2021Volume: 299Issue: 2pp. 261-263Anatomic and Functional Prostate Cancer ImagingRadiology2021Volume: 301Issue: 2pp. 387-388Artificial Intelligence in PET/CT Is about to Make Whole-Body Tumor Burden Measurements a Clinical RealityRadiology2019Volume: 294Issue: 2pp. 453-454Invited Commentary: Nuclear Theranostics—The Path ForwardRadioGraphics2020Volume: 40Issue: 6pp. 1741-1742See More RSNA Education Exhibits Prostate Cancer: What We Already Know About What Is on the HorizonDigital Posters2020Towards Structured PET Reporting with PSMA Tracers in Prostate CancerDigital Posters2022The Light From The Unknown - PSMA PET/MR Staging For Prostate CancerDigital Posters2021 RSNA Case Collection Locally advanced, metastatic prostate adenocarcinomaRSNA Case Collection2020Bilateral ParagangliomasRSNA Case Collection2022Hydrogel infiltration into rectal wallRSNA Case Collection2020 Vol. 307, No. 4 Metrics Altmetric Score PDF download